C - Chemistry – Metallurgy – 12 – N
Patent
C - Chemistry, Metallurgy
12
N
C12N 15/31 (2006.01) A61K 39/07 (2006.01) C07K 14/32 (2006.01) C12N 1/21 (2006.01) C12N 7/01 (2006.01) C12N 15/86 (2006.01) A61K 48/00 (2006.01)
Patent
CA 2339355
Using the nontoxic protective antigen PA protein from B. anthracis, a method and composition for use in inducing an immune response which is protective against anthrax in subjects is described.
L'invention concerne un procédé et une composition permettant d'induire une réponse immunitaire qui constitue une protection contre l'anthrax chez les patients. Ce procédé et cette composition utilisent la protéine PA non toxique provenant du B. anthracis.
Lee John S.
Parker Michael D.
Pushko Peter
Smith Jonathan F.
Welkos Susan L.
Johnson Ernest Peter
U.s. Medical Research Institute Of Infectious Diseases
LandOfFree
Anthrax vaccine does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Anthrax vaccine, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Anthrax vaccine will most certainly appreciate the feedback.
Profile ID: LFCA-PAI-O-1519021